OverviewSuggest Edit

TesoRx Pharma is a pharmaceutical company developing oncology and hormonal therapies. It uses LiPax, a proprietary drug delivery platform to provide urology and oncology products. The company supplies medications for bladder and ovarian cancer, carcinoma, and malignant pleural mesothelioma. In addition, TesoRx provides an oral formulation designed to help restore normal testosterone levels in males with hypogonadism.


Latest Updates

Employees (est.) (Mar 2020)8

Key People/Management at TesoRx

Ramachandran R. Thirucote

Ramachandran R. Thirucote

Founder and Chief Executive Officer


Co-Founder and Chief Scientific Advisor
Show more

TesoRx Financials and Metrics

Summary Metrics

Founding Date


TesoRx total Funding

$21.8 m

TesoRx latest funding size

$10 m

Time since last funding

6 years ago
TesoRx's latest funding round in August 2014 was reported to be $10 m. In total, TesoRx has raised $21.8 m
Show all financial metrics

TesoRx Online and Social Media Presence

Embed Graph

TesoRx Frequently Asked Questions

  • When was TesoRx founded?

    TesoRx was founded in 2010.

  • Who are TesoRx key executives?

    TesoRx's key executives are Ramachandran R. Thirucote and Betageri.

  • How many employees does TesoRx have?

    TesoRx has 8 employees.

  • Who are TesoRx competitors?

    Competitors of TesoRx include Merrimack Pharmaceuticals, Calithera Biosciences and TESARO.